|
Market Closed -
Hong Kong S.E.
08:08:08 30/10/2026 GMT
|
5-day change | 1st Jan Change | ||
| 1.030 HKD | -2.37% |
|
-2.83% | -32.24% |
| 09-10 | Lee's Pharma Licenses Cancer Drug OC-3 From 1cBio; Shares Plummet 4% | MT |
| 08-31 | Lee's Pharmaceutical Holdings Limited Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
Chart: Technical Analysis
Hong Kong S.E.HKD
| Markets | Quality | ||
|---|---|---|---|
Hong Kong S.E.
| 950 | Delayed | |
Deutsche Boerse AG
| L1PA | Delayed | |
|
Börse Stuttgart
| L1PA | Delayed |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Bearish | Bearish |
| Resistance | 1.135 | 1.2 | 1.34 |
| Spread/Res. | -9.25% | -14.17% | -23.13% |
| Spread/Supp. | +0.00% | +7.29% | +19.77% |
| Support | 1.03 | 0.96 | 0.86 |
- Stock Market
- Stocks
- 950 Stock
- Charts Lee's Pharmaceutical Holdings Limited
Select your edition
All financial news and data tailored to specific country editions
